A detailed history of Banque Cantonale Vaudoise transactions in Amgen Inc stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 32,716 shares of AMGN stock, worth $10.6 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
32,716
Previous 32,028 2.15%
Holding current value
$10.6 Million
Previous $9.11 Million 12.26%
% of portfolio
0.41%
Previous 0.36%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$262.75 - $319.31 $180,772 - $219,685
688 Added 2.15%
32,716 $10.2 Million
Q1 2024

Apr 10, 2024

BUY
$268.87 - $324.56 $237,949 - $287,235
885 Added 2.84%
32,028 $9.11 Million
Q4 2023

Feb 07, 2024

BUY
$255.7 - $288.46 $1.68 Million - $1.89 Million
6,566 Added 26.72%
31,143 $8.97 Million
Q3 2023

Nov 08, 2023

SELL
$218.65 - $271.46 $318,354 - $395,245
-1,456 Reduced 5.59%
24,577 $6.61 Million
Q2 2023

Aug 09, 2023

SELL
$214.27 - $253.37 $1.01 Million - $1.2 Million
-4,726 Reduced 15.36%
26,033 $5.78 Million
Q1 2023

Apr 20, 2023

BUY
$225.79 - $275.2 $1.7 Million - $2.08 Million
7,546 Added 32.51%
30,759 $7.44 Million
Q4 2022

Feb 10, 2023

SELL
$229.03 - $291.01 $1.35 Million - $1.72 Million
-5,902 Reduced 20.27%
23,213 $6.1 Million
Q3 2022

Oct 17, 2022

BUY
$224.46 - $253.15 $180,914 - $204,038
806 Added 2.85%
29,115 $6.56 Million
Q2 2022

Aug 02, 2022

BUY
$230.71 - $256.74 $687,515 - $765,085
2,980 Added 11.77%
28,309 $6.89 Million
Q1 2022

May 09, 2022

SELL
$219.27 - $242.57 $970,708 - $1.07 Million
-4,427 Reduced 14.88%
25,329 $6.13 Million
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $1.08 Million - $1.24 Million
5,434 Added 22.34%
29,756 $6.69 Million
Q3 2021

Oct 29, 2021

SELL
$212.27 - $248.7 $2.52 Million - $2.95 Million
-11,870 Reduced 32.8%
24,322 $5.17 Million
Q2 2021

Aug 11, 2021

SELL
$233.58 - $259.14 $433,057 - $480,445
-1,854 Reduced 4.87%
36,192 $8.82 Million
Q1 2021

May 11, 2021

SELL
$221.91 - $258.6 $579,628 - $675,463
-2,612 Reduced 6.42%
38,046 $9.47 Million
Q4 2020

Feb 05, 2021

SELL
$216.38 - $257.67 $251,000 - $298,897
-1,160 Reduced 2.77%
40,658 $9.35 Million
Q3 2020

Oct 30, 2020

BUY
$234.65 - $260.95 $1.51 Million - $1.68 Million
6,426 Added 18.16%
41,818 $10.6 Million
Q2 2020

Jul 22, 2020

BUY
$197.81 - $242.74 $635,959 - $780,409
3,215 Added 9.99%
35,392 $8.35 Million
Q1 2020

May 14, 2020

SELL
$182.24 - $241.7 $269,897 - $357,957
-1,481 Reduced 4.4%
32,177 $6.52 Million
Q4 2019

Feb 10, 2020

BUY
$189.21 - $243.2 $6.37 Million - $8.19 Million
33,658 New
33,658 $8.11 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $173B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Banque Cantonale Vaudoise Portfolio

Follow Banque Cantonale Vaudoise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.